socalTECH

NOVEMBER 18, 2014

Bradbury has joined the company''s board. Bradbury is a member of life sciences consulting and investment firm BioBrit LLC; he also served as President and CEO of Amylin Pharmaceuticals. renova therapeutics biopharmaceuticals gene therapy congestive heart failure venture capital lifescience amylin' READ MORE>>.

Bradbury 138

Bradbury San Diego .Net Venture Capital 138

socalTECH

MAY 13, 2014

Bradbury, former CEO of Amylin Pharmacueticals, as a new Chairman of its board, and also added Sherman Atkinson as a Director of the company with the funding. liquidgrids liquid grids venture capital healthcare marketing advertising' The company said it has added Daniel M. READ MORE>>.

Bradbury 100

Bradbury Marketing Miramar Advertising 100

socalTECH

MAY 4, 2020

According to Alume, the funding came from angel investors, including co-founder Chrysa Mineo (formerly of Receptos and Neurocrine Biosciences) and Dan Bradbury (co-founder and Executive Chairman of Equillium, Inc. La Jolla-based biotechnology startup Alume Biosciences announced that it has raised $5.5M and former CEO of Amylin).

Bradbury 113

Bradbury Study Funding Startup 113

socalTECH

NOVEMBER 27, 2017

As part of the funding Dan Bradbury, the former CEO of Amylin Pharmaceuticals, has joined as executive chairman, and M Ventures' Edwards Kliphuis, along with Hikma Ventures' Lana Ghanem have both joined the company's board. Biolinq is led by CEO Jared Tangney.

Bradbury 113

Bradbury San Diego Funding Startup 113